GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hoechst Pakistan Ltd (KAR:HPL) » Definitions » Valuation Rank

Hoechst Pakistan (KAR:HPL) Valuation Rank


View and export this data going back to 2008. Start your Free Trial

What is Hoechst Pakistan Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Hoechst Pakistan Valuation Rank Related Terms

Thank you for viewing the detailed overview of Hoechst Pakistan's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoechst Pakistan (KAR:HPL) Business Description

Traded in Other Exchanges
N/A
Address
Korangi Industrial Area, Plot 23, Sector 22, Karachi, PAK, 74900
Hoechst Pakistan Ltd Formerly Sanofi-Aventis Pakistan Ltd is engaged in the manufacturing and selling of pharmaceutical and consumer healthcare products and vaccines. Its product profile includes Oral Anti-Diabetics, Emergency Care, Antibiotics, Anti-malaria, Epilepsy, Sleep Disorders, and others. Geographically, the company operates in Pakistan, Afghanistan, and others.